[Effect of somatostatin on basal and stimulated exocrine pancreatic secretion after partial duodenopancreatectomy. A clinical experimental study].
In a prospective trial 30 patients underwent pancreaticoduodenectomy (Whipple operation) for cancer. They were randomly assigned to receive Somatostatin (SST) (n = 15) or not (n = 15). SST was started at laparotomy with 250 micrograms/h and given over a period of 5 days. A small catheter, which was placed into the duct of the pancreatic remnant, gave access to the pancreatic juice. Volume, amylase, lipase and protein as well as bicarbonate outputs were analyzed. As regards endocrine function, insulin and glucagon plasma levels were measured. The nitrogen balance was calculated. A stimulation test was done on the fifth postoperative day. Six patients (3/3) were assessed as drop-outs. A significant reduction was found for volume, amylase, lipase, protein and bicarbonate with SST, this effect lasting for two days. Lipase however was reduced significantly for 5 days. Pancreatic exocrine function was reduced as well after stimulation, if SST was given. Insulin and glucagon were inhibited with SST, the latter more effectively. We found a positive nitrogen-balance as early as on the second postoperative day in the SST-group, whereas without SST this did not occur before the fourth postoperative day. This findings were significant on the third and fourth postoperative day. The inhibitoric effects of SST, which are demonstrated by our laboratory investigations, conform very well with a more favorable clinical course and a reduction of perioperative morbidity and mortality.
Klempa
I
I
Klinik für Allgemein- und Gefässchirurgie, Zentralkrankenhaus St.-Jürgen-Strasse Bremen.
Baca
I
I
Menzel
J
J
Schuszdiarra
V
V
D014670:Ampulla of Vater / Q000601:surgery*; D003138:Common Bile Duct Neoplasms / Q000097:blood / Q000601:surgery*; D004386:Duodenum / Q000601:surgery; D005260:Female; D005934:Glucagon / Q000097:blood*; D006801:Humans; D007260:Infusion Pumps; D007328:Insulin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000097:blood; D010180:Pancreatectomy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000097:blood / Q000601:surgery*; D011183:Postoperative Complications / Q000097:blood*; D011446:Prospective Studies; D012636:Secretory Rate / Q000187:drug effects; D013004:Somatostatin / Q000008:administration & dosage*
D007328:Insulin; D013004:Somatostatin; D005934:Glucagon; D009584:Nitrogen
Auswirkung von Somatostatin auf die basale und stimulierte exokrine Pankreassekretion nach partieller Duodenopankreatektomie. Eine klinische experimentelle Studie.